Neonatal administration of fluoxetine did not alter the anxiety indicators, but decreased the locomotor activity in adult rats inthe elevated plus-maze

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 4, 2008, Pages 844-847

  Ribas, Valdenilson Ribeiro ^a,e   Aniceto, Helena Karine Rufino ^a,d   De Martins, Hugo André Lima ^a   Ribas, Ketlin Helenise Dos Santos ^a   De Guerra Ribas, Renata Melo ^a,c   Fraga, Simone Do Nascimento ^a   Ribeiro Ribas, Valéria ^a   Vasconcelos, Célia Maria Mendes ^a,d   Viana, Marcelo Tavares ^a   Manhaes de Castro, Raul ^a,b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b SORBONNE UNIVERSITÉ   (France)

^c HOSPITAL BARÃO DE LUCENA   (Brazil)

^d 1993 a 2007   (Brazil)

^e Setor de Nutrição do HBL ^*  (Brazil)

Author keywords

Anxiety; Fluoxetine; Neonatal; Plus maze; Serotonin

Indexed keywords

FLUOXETINE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; FOOTSHOCK; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; RAT; TIME;

EID: 58149217128     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000600013     Document Type: Article

References (30)

1. Chopin P, Moret C, Briley M. Neuropharmacology of 5-hydroxytryptamine 1B/1D receptor ligands. Pharmacol Therapeutics 1994;62:385-405.
2. Manhães-de-Castro R, Peregrino A, Sourgey E, Barreto Medeiros JM, Deiró TCBJ. Depression: repercussion in serotonergic system. Neurobiologia 1998;62:45-55.
3. Rudolph R, Feiger AD. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression. J Affective Disord 1999;56:171-181.
4. Manhães-de-Castro R, Barreto Medeiros JM, Mendes da Silva C, et al. Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective reuptake inhibitor. Braz J Med Biol Res 2001;34:121-124.
5. Moeller F, Allen T, Cherek DR, Dougherty DM, Lane S, Swann AC. Ipsapirone neuroendocrine challenge: relationship to aggression as measured in the human laboratory. Psychiatry Res Ann NY Acad Sci 1998;81:31-38.
6. Jaiswal A, Upadhyay SN, Satyan KS, Bhattacharya SK. Behavioural effects of prenatal and postnatal undernutrition in rats. Indian J Exp Biol 1996;34:1216-1219.
7. Allikmets L, Matto V, Harro J. Do the antidepressants have anxiogenic action? Biol Psychiatry 1996;39:500-666.
8. Silva M, Alves CRR, Santarém EMM. Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze. Braz J Med Biol Res 1999;32:333-339.
9. Ansorge M, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004;306:879-881.
10. Fuller R, Wong DT. Serotonin reuptake blockers in vitro and in vivo. J Clin Psychopharmacol 1987;7(Suppl):S36-S43.
11. Blier P, Chaput Y, de Montigny C. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study of the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 1988;337:246-254.
12. Mongeau R, Blier P, de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 1997;23:145-195.
13. Resnick O, Miller M, Forbes W, et al. Developmental protein malnutrition: influences on the central nervous system of the rat. Neurosci Biobehav Rev 1979;3:233-246.
14. Picanço-Diniz C, Araújo MS, Borba JMC, Guedes RCA. NADPH-diaphorase containing and biocytin-labelled axon terminals in the visual cortex of adult rats malnourished during development. Nutr Neurosci 1998;1:35-48.
15. Manhães-de-Castro R, Cabral JE Filho, Costa JA, Costa FBR, Galindo MAC, Hecksher CA. Neonatal treatment with naloxone causes permanent hyperalgesia in rats. Braz J Med Biol Res 1993;26:747-751.
16. Manhães-de-Castro R, Barreto Medeiros JM, Mendes da Silva C, et al. Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective reuptake inhibitor. Braz J Med Biol Res 2001;34: 121-124.
17. Morgane P, Miller M, Kemper T, et al. The effects of protein alnutrition on the developing central nervous system in the rat. Neurosci Biobehav Rev 1978;2:137-230.
18. Sánchez C, Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression: are they all alike? Psychopharmacol 1997;129:197-205.
19. Silva R, Brandão ML. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analyses. Pharmacol Biochem Behav 2000;65:209-216.
20. Griebel G, Rodgers RJ, Perrault G, Sanger DJ. Risk assessment behaviour: evaluation of utility in the study of 5-HT - related drugs in the rat elevated plus-maze test. Pharmacol Biochem Behav 1997;57:817-827.
21. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Neurosci Methods 1985;14:149-167.
22. Treit D. Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models. In Rodgers JR, Cooper SJ (eds). 5-HT agonists, 5-HT3 antagonists and benzodiazepines. Their comparative behavioural Pharmacology. Chichester, UK: John Wiley Sons 1991:107-131.
23. Treit TDFM. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 1988;31:958-962.
24. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci Behav 1995;19:377-395.
25. Artigas F. 5 - HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 1993;14:262.
26. Hillegaart V, Hjorth S. Median raphe, but not dorsal raphe application of the 5-HT1A agonist 8-OH-DPAT stimulations rat motor activity. Eur J Pharmacol 1989;160:303-307.
27. Blier P, de Montigny C, Chaput Y. Modification of the serotonina system by the antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987;7(Suppl):S24-S35.
28. Stanford S. Prozac: panacea or puzzle? Trends Pharmacol Sci 1996; 17:150-154.
29. Handley S, Mc Blane JW. Opposite effects of fluoxetine in two animal models of anxiety. Braz J Pharmacol 1993;107-446 (abstract).
30. Hiemke C, Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Therapeutics 2000;85:11-28.